| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| abt-348 | aurora kinase a | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hematologic Neoplasms[MeSHID:D019337] |
0.05 | phase 2 | unknown |
| abt-348 | aurora kinase b | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hematologic Neoplasms[MeSHID:D019337] |
0.04 | phase 2 | unknown |
| abt-348 | aurora kinase c | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hematologic Neoplasms[MeSHID:D019337] |
0.17 | phase 2 | unknown |
| click here to return to the previous page | ||||||||